CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 190 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,878,096 | +98.2% | 129,502 | +145.1% | 0.01% | +100.0% |
| Q2 2023 | $2,965,708 | +37.5% | 52,827 | +10.8% | 0.00% | +33.3% |
| Q1 2023 | $2,156,431 | -41.2% | 47,677 | -47.2% | 0.00% | -50.0% |
| Q4 2022 | $3,669,394 | -99.9% | 90,268 | +47.7% | 0.01% | 0.0% |
| Q3 2022 | $3,994,519,000 | +1101.9% | 61,125 | +1017.7% | 0.01% | +500.0% |
| Q2 2022 | $332,351,000 | -75.8% | 5,469 | -75.0% | 0.00% | -50.0% |
| Q1 2022 | $1,374,224,000 | -28.9% | 21,893 | -14.2% | 0.00% | -33.3% |
| Q4 2021 | $1,932,693,000 | +1372.0% | 25,504 | +2074.3% | 0.00% | – |
| Q3 2021 | $131,294,000 | -30.1% | 1,173 | +1.1% | 0.00% | – |
| Q2 2021 | $187,792,000 | +160.8% | 1,160 | +96.3% | 0.00% | – |
| Q1 2021 | $72,013,000 | -96.8% | 591 | -96.0% | 0.00% | -100.0% |
| Q4 2020 | $2,242,602,000 | +275.9% | 14,647 | +105.3% | 0.00% | +300.0% |
| Q3 2020 | $596,604,000 | +28.4% | 7,133 | +12.8% | 0.00% | 0.0% |
| Q2 2020 | $464,824,000 | -71.4% | 6,325 | -83.5% | 0.00% | -66.7% |
| Q1 2020 | $1,626,593,000 | +2116.3% | 38,354 | +3082.9% | 0.00% | – |
| Q4 2019 | $73,391,000 | -92.8% | 1,205 | -95.1% | 0.00% | -100.0% |
| Q3 2019 | $1,015,814,000 | +2376.1% | 24,782 | +2745.2% | 0.00% | – |
| Q2 2019 | $41,024,000 | – | 871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |